Evidence map›Paper›PMID 42630678›Full record

ArticleBlood neoplasia2026

Homozygosity of germ line

Paola Guglielmelli, Chiara Maccari, Manjola Balliu, Giuseppe Gaetano Loscocco, Naseema Gangat, Valentina Boldrini, Giulio Capecchi, Leonardo Signori, Alessio Enderti, Giada Rotunno and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood neoplasia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Paola GuglielmelliDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Chiara MaccariDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Manjola BalliuDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Giuseppe Gaetano LoscoccoDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Naseema GangatDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Valentina BoldriniDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Giulio CapecchiDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Leonardo SignoriDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Alessio EndertiDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Giada RotunnoDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Chiara PaoliDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Sofia DanesiDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Cecilia MatteoliDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Francesco MannelliDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.
Tiziano BarbuiFROM Research Foundation, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Ayalew TefferiDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Alessandro Maria VannucchiDepartment of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione, Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42630678
PMCPMC13494403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.